【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 15
1.2 List of Figures 19
2 Introduction 21
2.1 Catalyst 21
2.2 Related Reports 22
3 Industry Overview 23
3.1 Nuclear Imaging Techniques 23
3.1.1 Positron Emission Tomography 23
3.1.2 Single-Photon Emission Computed Tomography 25
3.1.3 Planar Scintigraphy 25
3.1.4 Hybrid Imaging 26
3.2 Clinical Applications of Nuclear Imaging Technology 31
3.2.1 Cancer 31
3.2.2 Cardiology 33
3.2.3 Neurology 35
3.2.4 Infection and Inflammation 37
3.3 Advantages and Disadvantages of Nuclear Imaging Technologies 40
3.4 Market Access 41
3.4.1 Product Life Cycle 41
3.4.2 Purchasing Decisions 43
3.4.3 Equipment Leasing 49
3.4.4 Replacement of PET/CT by PET/MRI 49
3.5 Reimbursement 54
3.5.1 Overview 54
3.5.2 US 55
3.5.3 France 55
3.5.4 Germany 57
3.5.5 Italy 58
3.5.6 Spain 59
3.5.7 UK 60
3.5.8 Japan 61
3.5.9 Brazil 61
3.5.10 China 62
3.5.11 India 63
3.6 Procedure Trends 64
3.6.1 US 64
3.6.2 France 67
3.6.3 Germany 69
3.6.4 Italy 72
3.6.5 Spain 74
3.6.6 UK 76
3.6.7 Japan 79
3.6.8 Brazil 81
3.6.9 China 84
3.6.10 India 86
3.7 Regulatory Issues/Recalls 89
3.8 M&As and Key Partnerships 90
3.9 Economic Impact 92
3.9.1 US 92
3.9.2 Europe 95
4 Unmet Needs 96
4.1 Overview 96
4.2 Improved Reimbursement for New Techniques 96
4.3 Lack of Binding Clinical Guidelines 100
4.4 Patient Comfort and Convenience 100
4.5 Reducing Radiation Exposure 101
4.6 Improved Scanner Performance 103
4.7 Image Processing Software Improvements 104
4.8 Increased Risk of Artifacts in Hybrid Images 106
4.9 Demand for New Radiotracers 107
4.10 Improved Clinical Input into the Design Process 109
5 Market Opportunity Analysis 110
5.1 Cheaper, Simpler Nuclear Imaging Devices 110
5.2 SPECT/CT in Developing Countries 110
5.3 Increased Demand for Teleradiology Services 113
6 Market Drivers and Barriers 115
6.1 Driver: Aging Population and Increasing Disease Prevalence 115
6.2 Driver: Referring Physician Awareness 116
6.3 Driver: Defensive medicine 117
6.4 Driver: Patient Awareness 119
6.5 Driver: Self-Referral 119
6.6 Driver: New Imaging Agents 120
6.7 Driver: Increasing Demand for Cancer Diagnostic Tests 120
6.8 Driver: Companion Diagnostic Testing 121
6.9 Barrier: Comparative Effectiveness Research 122
6.10 Barrier: Reimbursement Legislation 124
6.11 Barrier: Increasing Demand for Nuclear Imaging in Developing Markets 124
6.12 Barrier: Insurance Company Lobbying to Reduce Unnecessary Imaging 126
6.13 Barrier: Greater Payer Scrutiny of EMRs 126
6.14 Barrier: Increased Use of Appropriateness Criteria 127
6.15 Barrier: Practice Guidelines to Reduce Unnecessary Procedures 129
6.16 Barrier: Imaging Facility Accreditation 129
6.17 Barrier: Loss of Nuclear Medicine Skills 130
6.18 Barrier: High Cost of Instruments and Reagents 131
6.19 Barrier: Radiopharmaceutical Cost and Supply Difficulties 132
6.20 Barrier: Medical Device Excise Tax 135
6.21 Barrier: Hospital Consolidation 135
7 Competitive Assessment 137
7.1 Overview 137
7.2 Dedicated PET Systems 137
7.2.1 Overview 137
7.2.2 Product Profile 138
7.2.3 SWOT Analysis 139
7.3 PET/CT Systems 139
7.3.1 Overview 139
7.3.2 Product Profiles 140
7.3.3 SWOT Analysis 142
7.4 PET/MRI Systems 142
7.4.1 Overview 142
7.4.2 Product Profile 144
7.4.3 SWOT Analysis 145
7.5 Dedicated SPECT Systems 145
7.5.1 Overview 145
7.5.2 Product Profile 147
7.5.3 SWOT Analysis 148
7.6 SPECT/CT Systems 149
7.6.1 Overview 149
7.6.2 Product Profile 151
7.6.3 SWOT Analysis 152
7.7 PET/Ultrasound and SPECT/Ultrasound Systems 153
7.7.1 Overview 153
7.7.2 Product Profile 153
7.7.3 SWOT Analysis 154
8 Pipeline Assessment 155
8.1 Overview 155
8.2 Pipeline by Phases in Development 156
8.3 Product Profiles 156
8.3.1 Brain Biosciences CerePET 156
8.3.2 ECORAD Dual Modality Imager 158
8.3.3 FMI Technologies ScintiStar PET/CT 159
8.3.4 IntraMedical Imaging Marginator Beta Camera 161
8.3.5 INSERT SPECT/MRI 162
8.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device 165
8.3.7 Philips Healthcare PET Alpha Ring Detector 166
8.3.8 Photo Diagnostic Systems NeuroPET/CT 167
8.3.9 SynchroPET Breast PET/MRI 168
8.3.10 SynchroPET Wrist Scanner 169
8.3.11 SurgicEye SPECT Hybrid 170
9 Clinical Trials to Watch 172
9.1 Overview 172
9.2 Clinical Trial Profiles 172
10 Current and Future Players 175
10.1 Overview 175
10.2 Trends in Corporate Strategy 175
10.3 Company Profiles 176
10.3.1 DDD-Diagnostic 176
10.3.2 Digirad 178
10.3.3 GE Healthcare 182
10.3.4 GVI Medical Devices 187
10.3.5 Mediso Medical Imaging Systems 189
10.3.6 NeuroLogica 191
10.3.7 Neusoft Medical Systems 194
10.3.8 NuCare Medical Systems 197
10.3.9 Oncovision 199
10.3.10 Philips Healthcare 201
10.3.11 Shimadzu 208
10.3.12 Siemens Healthcare 213
10.3.13 SurgicEye 219
10.3.14 Toshiba Medical 222
10.3.15 Other Companies 227
11 Market Outlooks 230
11.1 Company Market Share Analysis 230
11.1.1 Global Overview 230
11.1.2 US 231
11.1.3 France 231
11.1.4 Germany 232
11.1.5 Italy 233
11.1.6 Spain 234
11.1.7 UK 235
11.1.8 Japan 236
11.1.9 Brazil 237
11.1.10 China 238
11.1.11 India 239
11.2 Market Segment Share 240
11.2.1 SPECT & SPECT/CT 240
11.2.2 PET, PET/CT & PET/MRI 241
11.3 By Geography 243
11.3.1 Global Overview 243
11.3.2 US 246
11.3.3 France 248
11.3.4 Germany 250
11.3.5 Italy 252
11.3.6 Spain 255
11.3.7 UK 257
11.3.8 Japan 259
11.3.9 Brazil 262
11.3.10 China 265
11.3.11 India 268
12 Appendix 271
12.1 Abbreviations 271
12.2 Bibliography 276
12.3 Methodology 307
12.3.1 Overview 307
12.3.2 Coverage 307
12.3.3 Secondary Research 307
12.4 Physicians and Specialists Included in This Study 309
12.5 Primary Research 311
12.5.1 Primary Research – Key Opinion Leader Interviews 311
12.5.2 Expert Panel Validation 311
12.5.3 Stakeholder Survey 312
12.6 Forecasting Methodology 314
12.7 About the Authors 315
12.7.1 Andrew Thompson, PhD, Senior Analyst 315
12.7.2 Priya Radhakrishnan, MBA, Director, Medical Devices 315
12.7.3 Bonnie Bain, PhD, Global Head of Healthcare 316
12.8 About GlobalData 317
12.9 Disclaimer 317
【レポート販売概要】
■ タイトル：核医学診断装置（PET、SPECT）の世界市場■ 英文：MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts
■ 発行日：2014年12月15日
■ 調査会社：GlobalData
■ 商品コード：GDME0208MAR
■ 調査対象地域：グローバル
- 分注装置の世界市場予測The global dispensing systems market, in terms of value, is projected to reach USD 40.5 Billion by 2020 from USD 31.5 Billion in 2015, at a CAGR of 5.1% from 2015 to 2020. Dispensing systems are material dispensing equipment that help in applying controlled amounts of the adhesives, sealants, lubricants and other assembly fluids in manufacturing processes. This helps in increasing productivity in …
- 銅管の欧州・中東・アフリカ市場2017-2021About Copper Pipes and Tubes Copper is considered as a base metal like zinc, nickel, and aluminum, and is heavily used in industries like the power industry. The major contributing countries in the production of copper includes Chile, China, and Peru. Chile alone accounted for a share of more than 33% in the global production of copper in 2015 and is also by far the country with the largest copper …
- スマートカードICの世界市場2016-2020About Smart Card A smart card is made up of PVC, polyester, or polycarbonate and is embedded with an IC, an MCU, and a memory chip. The memory chip is embedded with a smart card IC that can store and process a large amount of data. The microcontroller helps to secure payment transactions with functions such as encryption and digital signatures. It provides a tamper-resistant system and protects in …
- 繊維試験装置の世界市場2017-2021About Textile Testing EquipmentTextile testing is an important part of textile production, consumption, and distribution. It is performed mainly to determine the properties of a textile material. Technavio’s analysts forecast the global textile testing equipment market to grow at a CAGR of 1.99% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the gr …
- Hardy Oil and Gas plc：石油・ガスバリューチェーン分析レポート2013Hardy Oil and Gas plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Hardy Oil and Gas plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Hardy Oil and Gas plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- M2M通信の世界市場：技術（有線、無線）、産業、地域別分析A combination of wired and wireless technologies that enables two or more machines of the same type other than smartphones, tablets, and wearables among others to communicate with each other is known as Machine-to-Machine (M2M). This report provides an in-depth analysis of the global M2M connections market based on different types of technology, verticals, and geography. The different verticals co …
- 苛性ソーダの世界市場2016-2020About Caustic Soda Caustic soda, also known as sodium hydroxide, is an odorless, highly corrosive, non-flammable white solid. It is generally produced as flakes or shiny pellets that make a slippery solution because it is highly water soluble. The 50% concentration of caustic soda is slightly viscous in nature. It is widely used as a general purpose industrial as well as commercial chemical in sev …
- 2014年戦略提言：世界の微生物検査市場Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S., five major Europe …
- 世界の美容機器開発動向：医療機器パイプライン分析2015Aesthetic Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The …
- 慢性骨髄性白血病(CML/慢性骨髄性白血病)：世界の臨床試験レビュー（2014年上半期）Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014" provides data on the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trial scenario. This report provides elemental information and d …
- トランスペアレントキャッシュの世界市場ABSTRACTAbout Transparent Cache Caching refers to the temporary storage of web content for faster subsequent access. Transparent cache is a solution that allows the service providers to offload a large amount of web content by storing a cached copy. Technavio’s analysts forecast the global transparent cache market to grow at a CAGR of 36.09% during the period 2017-2021. [Covered in this report] Th …
- 血管閉鎖装置（VCD）の世界市場の予測＆動向分析：製品別（アクティブ近似器、縫合ベースデバイス、クリップベースデバイス、受動近似器、コラーゲンプラグ、シーラント/ゲルベースデバイス、圧縮補助デバイス、外部止血デバイス）、エンドユーザー別（急性ケア施設、病院、診療所）、セグメント予測、2013-2024Global vascular closure devices (VCDs) market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption …
- 米飴（ライスシロップ）の世界市場2019-2023Global Rice Syrup Market: About this market Technavio’s rice syrup market analysis considers sales from both conventional rice syrup and organic rice syrup. Our analysis also considers the sales of rice syrup in APAC, Europe, MEA, North America, and South America. In 2018, the conventional rice syrup segment had a significant market share, and this trend is expected to continue over the forecast p …
- フェムトセルの世界市場2015-2019About femtocell A femtocell is a small and lightweight cellular base station designed to increase the signal strength and coverage area of mobile networks, indoors and outdoors. It offers prompt data connections, in-building voice and data services, fewer dropped calls, and improved mobile voice quality to enterprises and residential consumers. The femtocell technology can be easily deployed becau …
- Truvada (HIV)：市場予測と分析（～2022）Truvada (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Truvada (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a dea …
